Japan's Regulatory Authority Approves Biogen/Eisai's Alzheim

Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi - Eisai Co (OTC:ESALF), Biogen (NASDAQ:BIIB)

Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) and Biogen Inc (NASDAQ: BIIB) announced that humanized anti-soluble aggregated amyloid-beta (A&be

Related Keywords

Japan , , Ad Cooperative Study , Biogen Inc , Eisai Co Ltd , Leqembi Intravenous Infusion , Daily Living Scale , Mild Cognitive Impairment ,